Prevention of Brain Metastases HER2-positive Breast Cancer
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a recent article by Volkmar Müllera on X:
“Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer.
Patients with HER2-positive MBC have a significant risk developing BrM. Experts created statements regarding BrM prevention in HER2-positive MBC.
Using a modified Delphi process, experts reached consensus on 34 statements. Statements covered definitions, screening, treatment efficacy and prevention of BrM. These statements can provide guidance in daily practice and clinical trial design.”
Title: Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer.
Authors: Volkmar Müllera, Thomas Bachelotb, Giuseppe Curigliano, Evandro de Azambujae, Julia Furtnerf, Jens Gemptg, Barbara Alicja Jereczek-Fossac, Katarzyna J. Jerzaki, Emilie Le Rhunj, Carlo Palmierik, Gabriella Pravettonid, Cristina Sauran and Rupert Bartsch.
More posts featuring Elisabetta Bonzano.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023